Canada - Toronto Stock Exchange - TSX:JNJ -
JNJ gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 34 industry peers in the Pharmaceuticals industry. JNJ has an excellent profitability rating, but there are some minor concerns on its financial health. JNJ scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings would make JNJ suitable for value investing!
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.03% | ||
| ROE | 31.69% | ||
| ROIC | 14.16% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27% | ||
| PM (TTM) | 27.26% | ||
| GM | 68.14% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 2.34 | ||
| Altman-Z | 2.41 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.07 | ||
| Quick Ratio | 0.8 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 1.92 | ||
| Fwd PE | 1.79 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.55 | ||
| EV/EBITDA | 1.94 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.38% |
ChartMill assigns a fundamental rating of 7 / 10 to JNJ.CA.
ChartMill assigns a valuation rating of 9 / 10 to Johnson and Johnson (JNJ.CA). This can be considered as Undervalued.
Johnson and Johnson (JNJ.CA) has a profitability rating of 8 / 10.
The financial health rating of Johnson and Johnson (JNJ.CA) is 6 / 10.
The dividend rating of Johnson and Johnson (JNJ.CA) is 4 / 10 and the dividend payout ratio is 48.7%.